MERS-CoV antagonizes PKR activation by inhibiting its condensation at viral replication complexes

Ebba K Blomqvist1,2,3, Nicole Bracci4,5, Helena Winstone4,5

  • 1Department of Molecular Medicine, The Herbert Wertheim University of Florida Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA.

Insights

Middle East respiratory syndrome coronavirus (MERS-CoV) antagonizes the protein kinase R (PKR) pathway. MERS-CoV NS4a protein prevents PKR activation by blocking PKR condensation on viral dsRNA, a crucial step for innate immunity.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Middle East respiratory syndrome coronavirus (MERS-CoV) is a pathogenic virus that suppresses innate immune responses.
  • The protein kinase R (PKR) pathway is a key component of the innate immune system targeted by MERS-CoV.

Purpose of the Study:

  • To investigate the mechanism of PKR activation in response to MERS-CoV.
  • To elucidate how MERS-CoV antagonizes the PKR pathway.

Main Methods:

  • Utilized an immunostimulatory MERS-CoV mutant with an inactive endoribonuclease U and a deletion of accessory protein NS4a.
  • Observed PKR condensation and activation on viral dsRNA associated with double-membrane vesicles (DMVs).
  • Examined the role of MERS-CoV NS4a protein in PKR inhibition.

Main Results:

  • PKR activates by condensing on viral dsRNA near DMVs, then dissociates to phosphorylate eIF2α.
  • MERS-CoV NS4a protein inhibits PKR activation by binding to dsRNA and preventing PKR condensation.
  • PKR condensation and activation were also observed in response to Zika virus.

Conclusions:

  • PKR activation involves condensation on viral dsRNA at replication complexes, followed by autophosphorylation and cytosolic relocalization.
  • MERS-CoV NS4a antagonizes this antiviral pathway by inhibiting PKR condensation.
  • This study provides a model for PKR activation by positive-strand RNA viruses and MERS-CoV's immune evasion strategy.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K